National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
AI167910
米国
National Institutes of Health/National Center for Complementary and Integrative Health (NIH/NCCIH)
AT011966
米国
Michelson Prizes for Human Immunology and Vaccine Research
米国
Searle Scholars Program
米国
引用
ジャーナル: Nat Commun / 年: 2023 タイトル: High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike. 著者: Timothy J C Tan / Zongjun Mou / Ruipeng Lei / Wenhao O Ouyang / Meng Yuan / Ge Song / Raiees Andrabi / Ian A Wilson / Collin Kieffer / Xinghong Dai / Kenneth A Matreyek / Nicholas C Wu / 要旨: Designing prefusion-stabilized SARS-CoV-2 spike is critical for the effectiveness of COVID-19 vaccines. All COVID-19 vaccines in the US encode spike with K986P/V987P mutations to stabilize its ...Designing prefusion-stabilized SARS-CoV-2 spike is critical for the effectiveness of COVID-19 vaccines. All COVID-19 vaccines in the US encode spike with K986P/V987P mutations to stabilize its prefusion conformation. However, contemporary methods on engineering prefusion-stabilized spike immunogens involve tedious experimental work and heavily rely on structural information. Here, we establish a systematic and unbiased method of identifying mutations that concomitantly improve expression and stabilize the prefusion conformation of the SARS-CoV-2 spike. Our method integrates a fluorescence-based fusion assay, mammalian cell display technology, and deep mutational scanning. As a proof-of-concept, we apply this method to a region in the S2 domain that includes the first heptad repeat and central helix. Our results reveal that besides K986P and V987P, several mutations simultaneously improve expression and significantly lower the fusogenicity of the spike. As prefusion stabilization is a common challenge for viral immunogen design, this work will help accelerate vaccine development against different viruses.